Terence Flynn
Stock Analyst at Morgan Stanley
(4.67)
# 769
Out of 4,587 analysts
1043
Total ratings
58.6%
Success rate
10.8%
Average return
Main Sectors:
Stocks Rated by Terence Flynn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BMY Bristol-Myers Squibb Company | Reiterated: Sell | $40 | $64.86 | -38.33% | 49 | Jul 31, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Hold | $730 → $758 | $738.34 | +2.66% | 60 | Jul 31, 2026 | |
| BIIB Biogen | Maintained: Hold | $222 → $231 | $207.93 | +11.10% | 62 | Jul 30, 2026 | |
| JNJ Johnson & Johnson | Maintained: Buy | $294 | $255.82 | +14.92% | 57 | Jul 28, 2026 | |
| NRIX Nurix Therapeutics | Rated: Buy | $36 → $38 | $23.58 | +61.15% | 18 | Jul 28, 2026 | |
| GILD Gilead Sciences | Maintained: Buy | $166 → $165 | $131.28 | +25.69% | 61 | Jul 27, 2026 | |
| PFE Pfizer | Maintained: Hold | $28 | $24.91 | +12.40% | 59 | Jul 27, 2026 | |
| MRK Merck & Co. | Maintained: Hold | $113 | $129.79 | -12.94% | 54 | Jul 15, 2026 | |
| AMGN Amgen | Maintained: Hold | $340 → $333 | $387.64 | -14.10% | 54 | Jul 8, 2026 | |
| LLY Eli Lilly and Company | Maintained: Buy | $1,344 → $1,347 | $1,154.97 | +16.63% | 79 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $33 → $39 | $57.92 | -32.67% | 35 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $126 → $119 | $92.85 | +28.16% | 85 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.02 | - | 12 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $278 | $257.41 | +8.00% | 53 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $516 | $525.82 | -1.87% | 33 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $13.82 | +30.25% | 18 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 → $39 | $28.95 | +34.72% | 9 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $15 | $11.09 | +35.26% | 18 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $49 → $48 | $19.05 | +151.97% | 7 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 → $22 | $28.25 | -22.12% | 15 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $63 → $64 | $59.02 | +8.44% | 29 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $612 → $616 | $481.70 | +27.88% | 52 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 | $13.55 | -33.58% | 28 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 | $8.30 | +32.53% | 24 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 → $126 | $49.47 | +154.70% | 6 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $32 → $33 | $48.44 | -31.87% | 13 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.66 | - | 11 | Sep 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.69 | n/a | 6 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $16 | $50.03 | n/a | 13 | Jun 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $12 | $3.28 | n/a | 3 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €92.00 | €144.20 | n/a | 1 | Aug 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $42.21 | $8.43 | n/a | 1 | Dec 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $18 → $16 | $112.64 | n/a | 2 | Mar 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $163 → $155 | $205.48 | n/a | 5 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $22 | $78.20 | n/a | 1 | Jun 18, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $32 → $31 | $6.79 | n/a | 4 | Jul 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $46 | $32.75 | n/a | 4 | Jun 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $38 | $8.17 | n/a | 1 | Nov 18, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $36 | $4.78 | n/a | 1 | Jul 21, 2015 |
Bristol-Myers Squibb Company
Jul 31, 2026
Reiterated: Sell
Price Target: $40
Current: $64.86
Upside: -38.33%
Regeneron Pharmaceuticals
Jul 31, 2026
Maintained: Hold
Price Target: $730 → $758
Current: $738.34
Upside: +2.66%
Biogen
Jul 30, 2026
Maintained: Hold
Price Target: $222 → $231
Current: $207.93
Upside: +11.10%
Johnson & Johnson
Jul 28, 2026
Maintained: Buy
Price Target: $294
Current: $255.82
Upside: +14.92%
Nurix Therapeutics
Jul 28, 2026
Rated: Buy
Price Target: $36 → $38
Current: $23.58
Upside: +61.15%
Gilead Sciences
Jul 27, 2026
Maintained: Buy
Price Target: $166 → $165
Current: $131.28
Upside: +25.69%
Pfizer
Jul 27, 2026
Maintained: Hold
Price Target: $28
Current: $24.91
Upside: +12.40%
Merck & Co.
Jul 15, 2026
Maintained: Hold
Price Target: $113
Current: $129.79
Upside: -12.94%
Amgen
Jul 8, 2026
Maintained: Hold
Price Target: $340 → $333
Current: $387.64
Upside: -14.10%
Eli Lilly and Company
Jul 8, 2026
Maintained: Buy
Price Target: $1,344 → $1,347
Current: $1,154.97
Upside: +16.63%
Jul 8, 2026
Maintained: Hold
Price Target: $33 → $39
Current: $57.92
Upside: -32.67%
Jul 8, 2026
Maintained: Buy
Price Target: $126 → $119
Current: $92.85
Upside: +28.16%
Jul 8, 2026
Maintained: Hold
Price Target: n/a
Current: $3.02
Upside: -
Jun 22, 2026
Maintained: Buy
Price Target: $278
Current: $257.41
Upside: +8.00%
Jun 4, 2026
Maintained: Hold
Price Target: $516
Current: $525.82
Upside: -1.87%
May 28, 2026
Maintained: Buy
Price Target: $18
Current: $13.82
Upside: +30.25%
May 15, 2026
Maintained: Buy
Price Target: $38 → $39
Current: $28.95
Upside: +34.72%
May 13, 2026
Maintained: Hold
Price Target: $15
Current: $11.09
Upside: +35.26%
May 13, 2026
Maintained: Buy
Price Target: $49 → $48
Current: $19.05
Upside: +151.97%
May 11, 2026
Maintained: Hold
Price Target: $20 → $22
Current: $28.25
Upside: -22.12%
May 7, 2026
Maintained: Buy
Price Target: $63 → $64
Current: $59.02
Upside: +8.44%
May 5, 2026
Rated: Buy
Price Target: $612 → $616
Current: $481.70
Upside: +27.88%
Apr 10, 2026
Maintained: Hold
Price Target: $9
Current: $13.55
Upside: -33.58%
Mar 18, 2026
Maintained: Hold
Price Target: $11
Current: $8.30
Upside: +32.53%
Feb 27, 2026
Maintained: Buy
Price Target: $125 → $126
Current: $49.47
Upside: +154.70%
Feb 17, 2026
Maintained: Sell
Price Target: $32 → $33
Current: $48.44
Upside: -31.87%
Sep 21, 2025
Maintained: Hold
Price Target: n/a
Current: $3.66
Upside: -
Dec 13, 2024
Maintained: Hold
Price Target: n/a
Current: $2.69
Upside: n/a
Jun 1, 2021
Maintained: Sell
Price Target: $16
Current: $50.03
Upside: n/a
Aug 10, 2020
Maintained: Hold
Price Target: $21 → $12
Current: $3.28
Upside: n/a
Aug 3, 2020
Upgraded: Buy
Price Target: €92.00
Current: €144.20
Upside: n/a
Dec 2, 2019
Initiated Coverage: Hold
Price Target: $42.21
Current: $8.43
Upside: n/a
Mar 25, 2019
Downgraded: Hold
Price Target: $18 → $16
Current: $112.64
Upside: n/a
Aug 13, 2018
Maintained: Buy
Price Target: $163 → $155
Current: $205.48
Upside: n/a
Jun 18, 2018
Initiated Coverage: Hold
Price Target: $22
Current: $78.20
Upside: n/a
Jul 21, 2017
Downgraded: Hold
Price Target: $32 → $31
Current: $6.79
Upside: n/a
Jun 13, 2016
Maintained: Hold
Price Target: $46
Current: $32.75
Upside: n/a
Nov 18, 2015
Rated: Hold
Price Target: $38
Current: $8.17
Upside: n/a
Jul 21, 2015
Initiated Coverage: Hold
Price Target: $36
Current: $4.78
Upside: n/a